Shareholder Votes

Senmiao Technology Ltd shareholders approved Election of Directors at the 2026-06-11 meeting.

“Proposal 1 : The Company’s stockholders elected the following five nominees as directors, to serve until the next annual meeting of stockholders of the Company and until their respective successors are duly elected and qualified, by the following vote: Name For Withheld Broker Non-Votes Ronggang (Jonathan) Zhang 2,353,697 7,368 818,056 Chong Chen 2,353,707 7,358 818,056 Si (Simon) Li 2,353,752 7,313 818,056 Jie Gao 2,353,747 7,318 818,056 Xiaojuan Lin 2,353,662 7,403 818,056”

Xilio Therapeutics, Inc. shareholders approved Election of Class II directors at the 2026-06-10 meeting.

“On June 10, 2026, the Company held the 2026 Annual Meeting. The following is a summary of the matters voted on at that meeting and the results of the votes on such matters. 1. The Company’s stockholders elected Akintunde Bello, Ph.D., Daniel Curran, M.D., Robert Ross, M.D. and Yuan Xu, Ph.D., as Class II directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his or her successor has been duly elected and qualified. The results of the stockholders’ vote with respect to the election of such Class II directors were as follows: Votes For Votes Withheld Broker Non-Votes Akintunde Bello, Ph.D. 3,652,015 130,437 1,279,671 Daniel Curran, M.D. 3,709,598 72,854 1,279,671 Robert Ross, M.D. 3,719,795 62,657 1,279,671 Yuan Xu, Ph.D. 3,716,549 65,903 1,279,671”

AMERISAFE INC shareholders approved Approval of the Technical Amendments at the 2026-06-10 meeting.

“5. Approval of the Technical Amendments . The amendment to the Company’s Certificate of Formation to make the Technical Amendments was approved. Votes For Votes Against Abstentions Broker Non-Votes 15,937,796 39,198 2,461 1,148,775”

AMERISAFE INC shareholders rejected Approval of the Officer Exculpation Amendment at the 2026-06-10 meeting.

“4. Approval of the Officer Exculpation Amendment . The amendment to the Company’s Certificate of Formation to provide for officer exculpation was not approved, as the votes in favor did not exceed the required two-thirds of the Company’s outstanding shares of common stock. Votes For Votes Against Abstentions Broker Non-Votes 8,963,682 7,013,076 2,697 1,148,775”

AMERISAFE INC shareholders approved Ratification of appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for 2026 at the 2026-06-10 meeting.

“3. Ratification of appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for 2026 . The appointment of Ernst & Young was ratified. Votes For Votes Against Abstentions 16,694,687 430,980 2,563”

AMERISAFE INC shareholders approved Advisory vote to approve the Company’s compensation of its named executive officers at the 2026-06-10 meeting.

“2. Advisory vote to approve the Company’s compensation of its named executive officers . The compensation of the Company’s named executive officers, as disclosed in the 2026 Proxy Statement under “Executive Compensation” and discussed under “Compensation Discussion and Analysis,” was approved on an advisory basis. Votes For Votes Against Abstentions Broker Non-Votes 15,834,256 138,678 6,521 1,148,775”

AMERISAFE INC shareholders approved Election of directors at the 2026-06-10 meeting.

“1. Election of directors . The following director nominees were elected for terms expiring at the Company’s 2029 annual meeting of shareholders: Name Votes For Votes Withheld Broker Non-Votes Michael J. Brown 15,120,165 859,290 1,148,775 G. Janelle Frost 15,651,044 328,411 1,148,775 Sean M. Traynor 15,660,680 318,775 1,148,775”

Lumexa Imaging Holdings, Inc. shareholders approved Ratification of appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for the year ending December 31, 2026 at the 2026-06-10 meeting.

“2. At the Annual Meeting, the Company's stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026: Votes For Votes Against Abstentions 91,555,829 66,858 55,889”

Lumexa Imaging Holdings, Inc. shareholders approved Election of three Class I directors to serve until the 2029 Annual Meeting at the 2026-06-10 meeting.

“1. At the Annual Meeting, the Company's stockholders elected, by the vote indicated below, the following three persons as Class I directors to the Board, each to serve until the Company's 2029 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified, subject to their earlier death, resignation or removal: Name Votes For Votes Withheld Broker Non-Votes Lee Cooper 87,523,628 3,328,050 826,898 Brian Regan 80,044,532 10,807,146 826,898 Caitlin Zulla 87,156,663 3,695,015 826,898”

Fortrea Holdings Inc. shareholders approved Advisory (Non-Binding) Vote on the Compensation of the Company’s Named Executive Officers at the 2026-06-09 meeting.

“Proposal 3: Advisory (Non-Binding) Vote on the Compensation of the Company’s Named Executive Officers The proposal to approve, on an advisory (non-binding) basis, the compensation of the Company’s Named Executive Officers was approved based upon the following votes: Votes Votes Votes Broker For Against Abstained Non-Votes 73,544,293 3,877,113 140,980 8,632,580”

Fortrea Holdings Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2026-06-09 meeting.

“Proposal 2: Ratification of Appointment of Independent Registered Public Accounting Firm The appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 was ratified based upon the following votes: Votes Votes Votes For Against Abstained 86,104,449 71,295 19,222”

Fortrea Holdings Inc. shareholders approved Election of Directors at the 2026-06-09 meeting.

“Proposal 1: Election of Directors The following nominees were elected to the Company’s Board of Directors Votes Votes Votes Broker For Withheld Abstained Non-Votes Anshul Thakral 75,014,537 2,533,352 14,497 8,632,580 Peter M. Neupert 70,709,138 5,953,866 899,382 8,632,580 William J. Sharbaugh 74,923,196 2,623,178 16,012 8,632,580”

Angi Inc. shareholders approved Ratification of the appointment of Ernst & Young LLP as Angi’s independent registered public accounting firm for the 2026 fiscal year at the 2026-06-10 meeting.

“A proposal to ratify the appointment of Ernst & Young LLP as Angi’s independent registered public accounting firm for the 2026 fiscal year. This proposal was approved by the stockholders on the basis of the following voting results: FOR AGAINST ABSTAIN BROKER NON-VOTE 32,462,993 469,719 133,061 0”

Angi Inc. shareholders approved Approval of the amendment and restatement of the Amended and Restated Angi Inc. 2017 Stock and Annual Incentive Plan at the 2026-06-10 meeting.

“A proposal to approve the 2017 Stock Plan. This proposal was approved by the stockholders on the basis of the following voting results: FOR AGAINST ABSTAIN BROKER NON-VOTE 27,395,763 1,133,031 207,849 4,329,130”

Angi Inc. shareholders approved Election of three Class II members of the Angi board of directors at the 2026-06-10 meeting.

“A proposal to elect three Class II members of the Angi board of directors, each to hold office until the 2029 annual meeting of stockholders or until such director’s successor shall have been duly elected and qualified (or, if earlier, such director’s removal or resignation from the Angi board of directors). The stockholders elected each of the nominees to the Angi board of directors on the basis of the following voting results: FOR WITHHOLD BROKER NON-VOTE Sandra Buchanan 24,234,693 4,501,950 4,329,130 Thomas C. Pickett Jr. 27,635,782 1,100,861 4,329,130 Glenn H. Schiffman 20,722,477 8,014,166 4,329,130”

MONOLITHIC POWER SYSTEMS INC shareholders approved Approval, on an advisory basis, of the 2025 compensation of the Company’s named executive officers at the 2026-06-11 meeting.

“Approved, on an advisory basis, the 2025 compensation of the Company’s named executive officers.”

MONOLITHIC POWER SYSTEMS INC shareholders approved Ratification of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026 at the 2026-06-11 meeting.

“Ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026.”

MONOLITHIC POWER SYSTEMS INC shareholders approved Election of two Class I directors at the 2026-06-11 meeting.

“Elected two Class I directors to serve for three-year terms until the Company’s annual meeting of stockholders in 2029, or until their respective successors are duly elected and qualified.”

HOOKER FURNISHINGS Corp shareholders approved Advisory vote on compensation of named executive officers at the 2026-06-09 meeting.

“The Company’s shareholders approved, on an advisory basis, the compensation of its named executive officers as disclosed in the Company’s Proxy Statement for the Annual Meeting. The proposal was approved by the following vote: Votes For Votes Against Abstain Broker Non-votes 7,517,391 141,144 17,201 1,125,307”

HOOKER FURNISHINGS Corp shareholders approved Ratification of KPMG LLP as independent registered public accounting firm for fiscal year ending January 31, 2027 at the 2026-06-09 meeting.

“The Company’s shareholders ratified the selection of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending January 31, 2027 by the following vote: Votes For Votes Against Abstain Broker Non-votes 8,236,135 499,431 65,477 -”

HOOKER FURNISHINGS Corp shareholders approved Election of seven directors at the 2026-06-09 meeting.

“The Company’s shareholders elected each of the following seven directors to serve a one-year term on the Company’s Board of Directors by the following vote: Votes Votes Broker Director For Withheld Non-votes Maria C. Duey 7,326,188 349,548 1,125,307 Paulette Garafalo 7,328,427 347,309 1,125,307 Christopher L. Henson 7,571,704 104,032 1,125,307 Jeremy R. Hoff 7,534,686 141,050 1,125,307 Paul A. Huckfeldt 7,294,264 381,472 1,125,307 Tonya H. Jackson 7,328,693 347,043 1,125,307 Ellen C. Taaffe 6,856,106 819,630 1,125,307”

MEDALLION FINANCIAL CORP shareholders approved Non-Binding Advisory Vote to Approve Named Executive Officer Compensation at the 2026-06-09 meeting.

“The Company’s stockholders approved a non-binding advisory resolution to approve the 2025 compensation of the Company’s named executive officers, as described in the Company’s proxy statement, by the following votes: VOTES FOR VOTES AGAINST VOTES ABSTAINED 14,202,106 2,854,013 363,830”

MEDALLION FINANCIAL CORP shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2026-06-09 meeting.

“The Company’s stockholders ratified the appointment of Plante & Moran, PLLC as the Company’s independent registered public accounting firm for the year ending December 31, 2026 by the following votes: VOTES FOR VOTES AGAINST VOTES ABSTAINED 16,425,384 742,483 252,082”

MEDALLION FINANCIAL CORP shareholders approved Election of Class III Directors at the 2026-06-09 meeting.

“Shareholders elected each of the Company’s nominees to serve as Class III Directors, each for a term expiring at the 2029 Annual Meeting of Shareholders of the Company, and for the third consecutive annual meeting of shareholders with respect to which BIMIZCI Fund LLC (the “Dissident”) submitted notice of director nominations, did not elect any of the Dissident’s nominees, by the following votes: VOTES FOR VOTES WITHHELD COMPANY NOMINEES John Everets 14,905,644 2,476,122 Cynthia A. Hallenbeck 13,199,033 4,182,873 Alvin Murstein 12,785,454 4,596,312 DISSIDENT NOMINEES Eric Kelly 3,384,358 13,997,407 John Kiernan 4,711,028 12,670,737 Timothy Shanahan 2,038,133 15,343,773”

Corvus Pharmaceuticals, Inc. shareholders approved Non-Binding Advisory Vote to Approve the Compensation of the Company’s Named Executive Officers at the 2026-06-11 meeting.

“Proposal No. 3 —Non-Binding Advisory Vote to Approve the Compensation of the Company’s Named Executive Officers On a non-binding advisory basis, the Company’s stockholders approved the compensation of the Company’s named executive officers. Votes For Votes Against Abstain Broker Non-Votes 58,936,532 1,971,370 64,329 12,049,623”

Corvus Pharmaceuticals, Inc. shareholders approved Ratification of Selection of Independent Registered Accounting Firm at the 2026-06-11 meeting.

“Proposal No. 2 — Ratification of Selection of Independent Registered Accounting Firm The Company’s stockholders ratified the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. Votes For Votes Against Abstain 72,864,335 105,674 51,845”

Corvus Pharmaceuticals, Inc. shareholders approved Election of Class I Directors at the 2026-06-11 meeting.

“Proposal No. 1 — Election of Directors The Company’s stockholders elected the Class I director nominees below to the Company’s Board of Directors to hold office until the 2029 Annual Meeting of Stockholders or until his or her respective successor is elected and qualified or appointed, or the earlier of his or her death, resignation or removal. Class III Director Nominees Votes For Votes Withheld Broker Non - Votes Richard A. Miller, M.D. 58,275,179 2,697,052 12,049,623 Linda S. Grais, M.D., J.D. 53,185,380 7,786,851 12,049,623”

Dare Bioscience, Inc. shareholders approved Adjournment of meeting to solicit additional proxies for Proposal 6 if necessary at the 2026-06-11 meeting.

“Proposal 8 : Our stockholders approved the adjournment of the Meeting, if necessary or advisable, to solicit additional proxies in favor of Proposal 6 if there were not sufficient votes to approve Proposal 6 by the votes set forth below.”

Dare Bioscience, Inc. shareholders approved Adjournment of meeting to solicit additional proxies for Proposal 5 if necessary at the 2026-06-11 meeting.

“Proposal 7 : Our stockholders approved the adjournment of the Meeting, if necessary or advisable, to solicit additional proxies in favor of Proposal 5 if there were not sufficient votes to approve Proposal 5 by the votes set forth below.”

Dare Bioscience, Inc. shareholders approved Approval of amendment to 2022 Stock Incentive Plan to increase shares available by 1,500,000 at the 2026-06-11 meeting.

“Proposal 6 : Our stockholders approved the 2022 Plan Amendment by the votes set forth below.”

Dare Bioscience, Inc. shareholders approved Approval of potential future issuance of shares under equity line with Lincoln Park Capital Fund, LLC (Nasdaq rule) at the 2026-06-11 meeting.

“Proposal 5 : Our stockholders approved, in accordance with Nasdaq rules, the potential future issuance of shares of our common stock under our existing equity line with Lincoln Park Capital Fund, LLC by the votes set forth below.”

Dare Bioscience, Inc. shareholders approved Advisory vote on preferred frequency of holding advisory vote on executive compensation at the 2026-06-11 meeting.

“Proposal 4 : Our stockholders voted as follows with respect to the preferred frequency of holding an advisory vote on the compensation of our named executive officers.”

Dare Bioscience, Inc. shareholders approved Advisory approval of compensation of named executive officers at the 2026-06-11 meeting.

“Proposal 3 : Our stockholders approved, on an advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement by the votes set forth below.”

Dare Bioscience, Inc. shareholders approved Ratification of appointment of Haskell & White LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-11 meeting.

“Proposal 2 : Our stockholders ratified the appointment of Haskell & White LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026 by the votes set forth below.”

Dare Bioscience, Inc. shareholders approved Election of Class III directors at the 2026-06-11 meeting.

“Proposal 1 : Each of the director nominees identified in the table below was elected as a Class III director to hold office until our 2029 annual meeting of stockholders, and until their respective successor is duly elected and qualified, by the votes set forth below.”

Local Bounti Corporation/DE shareholders approved Approval of adjournment of the Annual Meeting, if necessary, to solicit additional proxies at the 2026-06-10 meeting.

“Stockholders approved the adjournment of the Annual Meeting, if deemed necessary or appropriate, to solicit additional proxies if there are not sufficient votes in favor of any of the foregoing proposals, based on the following votes: For 19,603,312 Against 264,120 Abstain 45,136 Broker Non-Votes 0”

Local Bounti Corporation/DE shareholders approved Approval of issuance of shares upon conversion of convertible note and issuance of shares underlying warrant to U.S. Bounti, LLC at the 2026-06-10 meeting.

“Stockholders approved, for purposes of complying with the rules of the New York Stock Exchange, (i) the issuance of up to 7,882,861 shares of Common Stock upon the conversion of the convertible note issued to U.S. Bounti, LLC (“U.S. Bounti”) pursuant to the Convertible Note and Warrant Purchase Agreement, dated as of March 13, 2026, between the Company and U.S. Bounti (the “Purchase Agreement”), and (ii) the issuance of up to 5,500,000 shares of Common Stock underlying the common stock purchase warrant issued to U.S. Bounti pursuant to the Purchase Agreement, based on the following votes: For 17,438,100 Against 31,910 Abstain 2,018 Broker Non-Votes 2,440,540”

Local Bounti Corporation/DE shareholders approved Ratification of appointment of WithumSmith+Brown, PC as independent registered public accounting firm for the year ending December 31, 2026 at the 2026-06-10 meeting.

“Stockholders ratified the appointment of WithumSmith+Brown, PC as our independent registered public accounting firm for the year ending December 31, 2026, based on the following votes: For 19,563,968 Against 303,008 Abstain 45,592 Broker Non-Votes 0”

Local Bounti Corporation/DE shareholders approved Election of two Class II directors to serve for three years and until their successors are elected and qualified or until their earlier resignation or removal at the 2026-06-10 meeting.

“Stockholders elected two Class II directors to our Board to serve for three years and until their successors are elected and qualified or until their earlier resignation or removal, based on the following votes: Nominee Mark J. Nelson Charles R. Schwab, Jr. For 17,364,520 17,459,161 Withheld 107,508 12,867 Broker Non-Votes 2,440,540 2,440,540”

CapsoVision, Inc shareholders approved Ratification of the appointment of Baker Tilly US, LLP as the Company's independent registered public accounting firm for the 2026 fiscal year at the 2026-06-11 meeting.

“Proposal #2 for the ratification of the appointment of Baker Tilly US, LLP as the Company's independent registered public accounting firm for the 2026 fiscal year was approved.”

CapsoVision, Inc shareholders approved Election of Class I Directors at the 2026-06-11 meeting.

“Proposal #1 for the election (re-election) of the Class I Directors. The nominees listed below were re-elected at the Meeting to serve as Class I Directors of the Company until the Company's 2029 annual meeting of stockholders.”

AbCellera Biologics Inc. shareholders approved Non-binding advisory vote on compensation of named executive officers (Say-on-Pay) at the 2026-06-11 meeting.

“The Company’s shareholders approved Proposal 3. The votes cast at the Annual Meeting were as follows: For Against Abstain 142,831,950 10,932,105 435,917 The broker non-votes for this Proposal 3 totaled 36,576,359 common shares.”

AbCellera Biologics Inc. shareholders approved Ratification of appointment of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-11 meeting.

“The Company’s shareholders approved Proposal 2. The votes cast at the Annual Meeting were as follows: For Against Abstain 189,927,972 552,429 295,930”

AbCellera Biologics Inc. shareholders approved Election of John S. Montalbano, CFA, and Stephen R. Quake, D.Phil. as Class III directors at the 2026-06-11 meeting.

“The Company’s shareholders approved the election of John S. Montalbano, CFA, and Stephen R. Quake, D.Phil., as Class III directors recommended for election in Proposal 1 at the Annual Meeting. The Company’s shareholders voted for the Class III directors as follows: Nominee For Against Abstain John S. Montalbano, CFA 141,430,732 12,723,342 45,898 Stephen R. Quake, D.Phil. 149,019,960 5,113,056 66,956 The broker non-votes for this Proposal 1 totaled 36,576,359 common shares.”

KVH INDUSTRIES INC DE shareholders approved Ratification of Grant Thornton LLP as independent registered public accounting firm at the 2026-06-10 meeting.

“Proposal #3 - To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm. Number of Votes Cast For Number of Votes Cast Against Number of Abstentions 16,991,919 239,754 10,068”

KVH INDUSTRIES INC DE shareholders approved Advisory (non-binding) approval of named executive officer compensation at the 2026-06-10 meeting.

“Proposal #2 - To approve, on an advisory (non-binding) basis, the compensation of our named executive officers in 2025. Number of Votes Cast For Number of Votes Cast Against Number of Abstentions Number of Broker Non-Votes 11,616,563 2,236,796 84,449 3,303,933”

KVH INDUSTRIES INC DE shareholders approved Election of Class III directors at the 2026-06-10 meeting.

“Proposal #1 - To elect two Class III directors to a three-year term. Name of Director Nominee Number of Votes Cast For Number of Votes Cast Against Number of Abstentions Number of Broker Non-Votes David M. Tolley 9,904,925 4,030,794 2,089 3,303,933 Stephen H. Deckoff 7,601,581 6,334,009 2,218 3,303,933”

Cherry Hill Mortgage Investment Corp shareholders rejected Proposed amendment to the charter to remove the Board of Directors' exclusive power to amend the bylaws and make new bylaws at the 2026-06-11 meeting.

“The proposal to approve the Charter Amendment was not approved. The voting results of the proposal to approve the Charter Amendment were as follows: Votes For Votes Against Abstentions Broker Non-Vote 9,644,152 1,384,973 208,061 11,592,342”

Cherry Hill Mortgage Investment Corp shareholders approved Ratification of the appointment of Ernst & Young LLP as the independent public auditors for the fiscal year ending December 31, 2026 at the 2026-06-11 meeting.

“The proposal to ratify the Company’s appointment of EY as the Company’s independent public auditors for the fiscal year ending December 31, 2026 was approved based on the following votes for, votes against, and abstentions: Votes For Votes Against Abstentions 20,191,515 2,116,312 521,701”

Cherry Hill Mortgage Investment Corp shareholders approved Non-binding advisory approval of the compensation of the named executive officers for the year ended December 31, 2025 at the 2026-06-11 meeting.

“The proposal to approve, on a non-binding, advisory basis, the compensation of the Company’s named executive officers for the year ended December 31, 2025, as described in the proxy statement for the Annual Meeting, was approved based on the following votes for, votes against, abstentions, and broker non-votes: Votes For Votes Against Abstentions Broker Non-Vote 7,958,045 2,415,169 863,972 11,592,342”